diabetes-congress-prague-2019-scientifictracks

2 / 5

allied
academies
Page 22
Notes:
Journal of Diabetology | Volume 3
May 16-17, 2019 | Prague, Czech Republic
Diabetes and Endocrinology
27th International Conference on
J Diabetol, Volume 3
Optimizing treatment for diabetic patients with integrated approach of behavioral
management, food science, artificial intelligence and pharmaceutical care
Ahmad Hussen Tareq
Nanyang Technological University, Singapore
Diabetes is a major, non-communicable disease with
increasing prevalence at a global level. Optimized
diabetic care comprises of various factors. It starts from right
medications,frequentbloodglucosemonitoring,modification
indiet,increasingphysicalexertionandbehavioralintervention
for patient compliance. Pharmaceutical care addresses the
drug related issues and assist in sustaining desired blood
glucose levels. However, lifestyle changes are the significant
component of diabetes management. To adjust with these
changes patient needs continuous education, motivation
and monitoring. To track patient progress, pharmaceutical
care and behavioral challenges, we are developing tool to
manage clinical data, applying artificial intelligence and data
analytics to acquire expedient actionable insights for the
clinicians. Our focus is to resolve behavioral challenges of
patients particularly with diet. With reference to South Asia,
diet transition is significant part of disease management,
and it poses high barrier for patient compliance. Most
diabetics are accustomed to refined carbohydrate with
high glycemic index (GI) food. They have difficulty following
dietary recommendation for long term. The likely causes of
poor adherence are headaches, craving for carbohydrates,
habituation for their preferred food choices like white rice,
noodles and bread. We are developing a composite to
incorporate it into raw food ingredients. Aim is to enable food
production with lower GI. It will potentially help in addressing
the challenges of nutritional adherence in diabetic patients.
Although further research is needed to understand and
explore this route, nevertheless it offers a promising route
to replace high GI products with medium/low GI products.
Speaker Biography
Ahmad Hussen Tareq is pharmacist and scientist who did extensive
work in peptide engineering, its application in infectious diseases drug
development and nutrition sciences. After completing his PhD from NTU,
Singapore, he has been extensively involved with the deep tech startup
ecosystem of Singapore. Recently, he is building his own startup focused
on developing optimized nutritional care and behavior compliance for
diabetics. As a pharmacist, he worked with numerous diabetic patients,
particularly in developing countries with aim of reversing type 2 diabetes.
Hiswork isfocusedonusing integratedapproachofbehaviormanagement,
AI, sports science, big data, optimized nutritional & pharmaceutical care.
e: